BCBSAZ covers expanded range of COVID-19 vaccine boosters
To help increase protection against severe disease and complications from COVID-19, the FDA has amended the emergency use authorizations to expand the eligibility for vaccine booster doses. Below is a compiled list of the eligible populations and recommended time frames for the authorized boosters and the third mRNA dose, based on the CDC’s recent guidance.
Coverage, cost share, reimbursement, and billing
Blue Cross® Blue Shield® of Arizona (BCBSAZ) member cost share, provider reimbursement, and billing requirements for the authorized administration of a booster or third mRNA dose (as indicated above) will follow the same general guidelines currently in place for COVID-19 vaccines. Please refer to our December 15, 2020, provider notice. We are updating our system to accommodate coverage and reimbursement for the recent FDA emergency use authorizations.
Reminder: We add new codes into our claim system after the official announcement has been made by AMA or CMS. Claims submitted before or during the four- to six-week implementation period may be rejected or pended until the implementation is complete.
If you have questions, please contact your provider liaison or call Provider Partnerships at 602-864-4231 or 1-800-232-2345, ext. 4231.